medline.ch Onkologie Respirationstrakt

	Adherence to lifelines diet is associated with lower lung cancer risk in 98,459 participants aged 55â€‰years and above: a large prospective cohort study. Front Nutr Shi Y, Xin L, Peng L, Xu Z, Liu H, Wei Q, Tan W, Wang Y, Xiang L, Gu H. PMID: 39507907 [PubMed]
	Clinical utility of circulating tumor DNA profiling in detecting targetable fusions in non-small cell lung cancer. Front Oncol Kim YG, Lee B, Ha C, Lee C, Jung HA, Sun JM, Lee SH, Ahn MJ, Choi YL, Park S, Kim JW. PMID: 39507756 [PubMed]
	Lung enteric-type adenocarcinoma with gastric metastasis: a rare case report and literature review. Front Immunol Li X, Ma K, Ma X, Zhao X, Fan M, Xu Y. PMID: 39507527 [PubMed - indexed for MEDLINE]
	Association of concomitant H1 antihistamine and immune checkpoint inhibitor therapy on survival outcome and safety in patients with advanced primary lung cancer: a cohort study. Transl Lung Cancer Res Zhang WH, Li BX, Ma CX, Wang J, Yang F, Xiong YJ, Li SZ, Zhang JL, Du WJ, Hui ZZ, Shen M, Zhou L, Li RM, Tian X, Han Y, Ren BZ, Ichiki Y, Lee SC, Zhang XW, Cao S, Ren XB, Liu L. PMID: 39507043 [PubMed]
	Insights into sex differences in perioperative outcomes of non-small cell lung cancer patients. Transl Lung Cancer Res Zheng Q, Zhou J, Zhang Y, Wang T, Wu D, Pu Q, Mei J, Liao H, Liu L. PMID: 39507041 [PubMed]
	TQB2450 with or without anlotinib as maintenance treatment in subjects with locally advanced/unresectable non-small cell lung cancer that have not progressed after prior concurrent/sequential chemoradiotherapy (R-ALPS): study protocol for a randomized, double-blind, placebo-controlled, multicenter phase III trial. Transl Lung Cancer Res Dong B, Chen L, Pang Q, Jiang O, Ge H, Cheng Y, Zhou R, Meng X, Li J, Zhu X, Wang X, Cao Q, Ji Y, Chen M. PMID: 39507039 [PubMed]
	Prognostic significance of bone metastasis and clinical value of bone radiotherapy in metastatic non-small cell lung cancer receiving PD-1/PD-L1 inhibitors: results from a multicenter, prospective, observational study. Transl Lung Cancer Res Dong H, Lan A, Gao J, An Y, Chu L, Yang X, Chu X, Hu J, Chu Q, Ni J, Zhu Z. PMID: 39507037 [PubMed]
	Phase II study of ramucirumab and docetaxel for previously platinum-treated patients with non-small cell lung cancer and malignant pleural effusion (PLEURAM study). Transl Lung Cancer Res Takemoto S, Fukuda M, Ogata R, Senju H, Sugasaki N, Nakatomi K, Tomono H, Suyama T, Sasaki E, Matsuo M, Akagi K, Hayashi F, Dotsu Y, Ono S, Honda N, Taniguchi H, Gyotoku H, Ikeda T, Nagashima S, Soda H, Kinoshita A, Mukae H. PMID: 39507035 [PubMed]
	The time-to-surgery interval and its effect on pathological response after neoadjuvant chemoimmunotherapy in non-small cell lung cancer: a retrospective cohort study. Transl Lung Cancer Res Lin SD, Tong CY, Huang DD, Rossi A, Adachi H, Miao M, Zheng WX, Guo J. PMID: 39507028 [PubMed]
	Systems mapping: a novel approach to national lung cancer screening implementation in Australia. Transl Lung Cancer Res Marjanovic S, Page A, Stone E, Currie DJ, Rankin NM, Myers R, Brims F, Navani N, McBride KA. PMID: 39507020 [PubMed]
	Exposure-lag response of surface net solar radiation on lung cancer incidence: a global time-series analysis. Transl Lung Cancer Res Lu X, Wang R, Li J, Lyu S, Zhang J, Wang Q, Chi W, Zhong R, Chen C, Wu X, Hu R, You Z, Mai Y, Xie S, Lin J, Zheng B, Zhong Q, He J, Liang W. PMID: 39507019 [PubMed]
	Blood biomarkers to predict the efficacy of neoadjuvant chemo-immunotherapy in non-small cell lung cancer patients. Transl Lung Cancer Res Pan Y, Jin X, Hong J, Wang Y, Xu H, Lin J, Zhang Y, Yin K, Zhang J, Inamura K, Liu D, Li F, Zeng J. PMID: 39507016 [PubMed]
	What do we know about the role of neoadjuvant targeted therapy in early-stage EGFR-mutant and ALK-fused non-small cell lung cancer?-a narrative review of the current literature. Transl Lung Cancer Res Kemper M, Elges S, Kies P, Wiebe K, Lenz G, Bleckmann A, Evers G. PMID: 39507015 [PubMed]
	Efficacy and safety of tyrosine kinase inhibitors with thoracic radiotherapy for patients with oncogene-mutated non-small cell lung cancer: a meta-analysis. Radiat Oncol Li W, Wu P, Liang Z, Li L, Chen Y, Zhang W, Zhang H, Fang C. PMID: 39506792 [PubMed - indexed for MEDLINE]
	A prospective multi-cohort study identifies and validates a 5-gene peripheral blood signature predictive of immunotherapy response in non-small cell lung cancer. Mol Cancer Chen S, Liu F, Fu Y, Deng CK, Borgia JA, Ayman AG, Nasu M, Jijiwa M, Yang H, Gong T, Wang J, Ling Z, Wang X, Wang H, Chu Q, Deng Y. PMID: 39506771 [PubMed - indexed for MEDLINE]
	A study protocol for a mixed-method environmental scan of contextual factors that influence lung cancer screening adherence. Implement Sci Commun Hirsch EA, Fathi J, Ciupek A, Carter-Bawa L. PMID: 39506762 [PubMed]
	Preoperative prediction of occult lymph node metastasis in patients with non-small cell lung cancer: a simple and widely applicable model. BMC Pulm Med Li JX, Feng GY, He KL, Li GS, Gao X, Yan GQ, Wei LQ, He X, Li Y, Fu ZW, Liu J, Zhou HF. PMID: 39506749 [PubMed - indexed for MEDLINE]
	Cardiotoxicity following thoracic radiotherapy for lung cancer. Br J Cancer Walls GM, Bergom C, Mitchell JD, Rentschler SL, Hugo GD, Samson PP, Robinson CG. PMID: 39506136 [PubMed - as supplied by publisher]
	The association between breast cancer and lung cancer: a bidirectional Mendelian randomization study. Sci Rep Li X, Liu J, Zhang J, Wang Y, He J, Zhang H. PMID: 39505936 [PubMed - indexed for MEDLINE]
	Phase II randomized study of maintenance atezolizumab (A) versus atezolizumab + talazoparib (AT) in patients with SLFN11 positive extensive stage small cell lung cancer. S1929. J Thorac Oncol Karim NA, Miao J, Reckamp KL, Gay CM, Byers LA, Zhao YQ, Redman MW, Carrizosa DR, Wang WL, Petty WJ, Mehta K, Faller BA, Agamah ES, Kasbari SS, Malisetti RK, Kumar A, Schallenkamp J, Alluri KC, Gray JE, Kelly K. PMID: 39505259 [PubMed - as supplied by publisher]

Artikel 1 - 20 / 142588

Seite 1 von 7130

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung